S2-E60 – Explore Major Events and Issues for NAFLD and NASH At Our NASH-TAG 2022 Preview
The Surfers and guest Jörn Schattenberg review NASH-TAG 2022, a unique event and the first meeting on the 2022 NAFLD and NASH calendar.
December 9, 2021
The Surfers and guest Jörn Schattenberg review NASH-TAG 2022, a unique event and the first meeting on the 2022 NAFLD and NASH calendar.
Profs. Scott Friedman and Michelle Long, Dr. Naim Alkhouri and Global Liver Institute DIrector of Global NASH Programs Jeff McIntyre join Louise Campbell and Roger Green to review some of the most important and exciting presentations from the first three days of the 2021 TLMdX, the annual meeting from AASLD.
Manal Abdelmalek, Ken Cusi and Jörn Schattenberg join Louise Campbell and Roger Green to discuss key presentations at AASLD 2021 and preview SurfingNASH’s coverage of the event. This virtual meeting runs from November 12-15 and is scheduled on East Coast time.
Alina Allen and Ian Rowe lead the Surfers in considering biopathological shortcomings in fibrosis as a solitary endpoint. Their comments stem from Alina’s presentation of the recent Mayo Clinic paper, “MRE for Prediction of Long-Term Progression and Outcome in Chronic Liver Disease: A Retrospective Study.” In this conversation, Alina summarizes the paper, after which Stephen Harrison asks questions about the availability of subgroup analysis.
Alina Allen and Ian Rowe discuss how Liver Stiffness Measurements (LSM) can improve individual patient treatment in pre-cirrhotic and compensated cirrhotic patients. Their comments stem from Alina’s presentation of the recent Mayo Clinic paper, “MRE for Prediction of Long-Term Progression and Outcome in Chronic Liver Disease: A Retrospective Study.” In this conversation, Alina summarizes the paper, after which Stephen Harrison asks questions about the availability of subgroup analysis.
Alina Allen and Ian Rowe join the Surfers to discuss the recent Mayo Clinic paper, “MRE for Prediction of Long-Term Progression and Outcome in Chronic Liver Disease: A Retrospective Study.” In this conversation, Alina summarizes the paper, after which Stephen Harrison asks questions about availability of subgroup analysis.
Professors Alina Allen and Ian Rowe join the Surfers to discuss our ability to predict long-term outcomes using MR Elastography. The conversation flows around Mayo Clinic’s recent Hepatology publication, “MRE for prediction of long term progression and outcome in chronic liver disease.
Professor and epidemiologist Dr. Michelle Long joins Louise Campbell and Roger Green to discuss the important Fatty Liver stories of the last few months. She focuses on the recent paper on prevalence of NAFLD and NASH in an unselected middle-aged population.
Ian Rowe, Michelle Long and Manal Abdelmalek reveal what they consider the most important NAFLD/NASH stories of summer.
Jörn Schattenberg joins the Surfers to discuss drug development in cirrhosis. This conversation constitutes a call to action for the Surfers and our listeners.